サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1477175

コンパニオン診断市場：製品タイプ別、用途別、技術別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測

Companion Diagnostics Market, By Product Type, By Application, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
コンパニオン診断市場：製品タイプ別、用途別、技術別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測
出版日: 2024年05月07日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

コンパニオン診断の市場規模は2023年に69億7,812万米ドルとなり、2024年から2032年にかけてCAGR 12.2%で拡大

コンパニオン診断市場：市場力学

個別化医療の重要性の高まり

個々の患者の特定の遺伝子構成や特徴に合わせた治療が可能になるため、個別化医薬品に対する認識が高まっています。コンパニオン診断は、患者が特定の治療にどのように反応するかを予測できるバイオマーカーや遺伝子変異の同定に役立ちます。これにより、医師は患者固有の遺伝子プロファイルに基づいて、各患者に最も適した薬剤を処方することができます。このような検査により、ヘルスケア・プロバイダーは十分な情報に基づいた臨床判断を下し、不必要な事象のリスクを回避することができます。従って、個別化医薬品とコンパニオン診断の重要性の高まりは、より正確で効果的な患者中心の治療アプローチへのヘルスケアにおけるパラダイムシフトを意味します。

コンパニオン診断市場：主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約12.2%のCAGRで毎年成長すると推定されています。

製品タイプ別では、アッセイ、キット＆試薬分野が市場を独占しました。

エンドユーザー別では、製薬・バイオテクノロジー分野が市場を独占しており、予測期間中もその優位性を維持するとみられます。

地域別では、北米が2023年の収益をリードしました。

コンパニオン診断市場：セグメンテーション分析：

コンパニオン診断の世界市場は、製品タイプ、技術、用途、エンドユーザー、地域に基づいてセグメント化されます。

製品タイプにより、アッセイ、キット＆試薬、ソフトウェア＆サービスの2つに分類されます。アッセイ、キット＆試薬分野は、多様な製品が入手可能であること、アッセイやヘルスケア分野での利用が拡大していることから、市場を独占しています。

市場はエンドユーザーによって、製薬・バイオテクノロジー企業、臨床研究機関、リファレンスラボの3つに分類されます。製薬・バイオテクノロジー分野が市場を独占しており、予測期間中もその優位性は維持されるであろう。コンパニオン診断の採用が増加している背景には、ヘルスケア業界における医薬品開発の重要性が高まっていることがあります。

コンパニオン診断市場：地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

コンパニオン診断市場は北米が支配的です。数多くの著名なコンパニオン診断ベンダーやオープンな臨床研究施設が存在すること、技術的に進歩した機器やツールが容易に入手できること、米国やカナダにおける医療サービスのインフラが大きく変化していることなどが、北米におけるコンパニオン診断市場の成長に寄与しています。さらに、アジア太平洋地域は人口が多く、コンパニオン診断に対する認識が高まっており、医療インフラが整備され、最先端の治療に対する需要が高まっているため、市場参入企業に有利な機会を提供しています。例えば、2023年11月、FDAはFoundationOne CDxを、治療の対象となるホルモン受容体陽性の進行乳がん患者を同定するコンパニオン診断として使用することを承認しました。

コンパニオン診断市場：競合情勢：

強力な国際的プレゼンスと販売網を有する企業は、世界中のヘルスケアプロバイダーや患者へのリーチにおいて優位性を有します。コンパニオン診断の主な市場参入企業には、Abbott Molecular Inc.、Thermo Fisher Scientific Inc.、Dako Inc.、Qiagen Ltd.などがあり、コンパニオン診断の開発において明確な技術力と専門知識を有しています。例えば、サーモフィッシャーサイエンティフィック社は分子診断の専門家として知られており、この分野で幅広い製品を提供しています。コンパニオン診断市場では、FDA承認や欧州のCEマーキングなどの規制要件への適合が極めて重要です。規制当局の承認や品質基準の遵守に成功した実績のある企業は、より強いポジションを有する可能性があります。

目次

第1章 コンパニオン診断市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 コンパニオン診断の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 コンパニオン診断業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 コンパニオン診断市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 コンパニオン診断市場情勢

  • コンパニオン診断市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 コンパニオン診断市場：製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • アッセイ、キット、試薬
    • ソフトウェアとサービス

第8章 コンパニオン診断市場：用途別

  • 概要
    • 用途別セグメントシェア分析
    • 腫瘍学
    • 心血管疾患
    • 感染症
    • 神経疾患

第9章 コンパニオン診断市場：技術別

  • 概要
    • 技術別セグメントシェア分析
    • 免疫組織化学
    • 分子診断
    • In-situハイブリダイゼーション
    • FISH
    • CISH

第10章 コンパニオン診断市場：エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 製薬・バイオテクノロジー企業
    • 臨床研究機関
    • リファレンスラボ

第11章 コンパニオン診断市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：コンパニオン診断業界

  • 競合ダッシュボード
  • 企業プロファイル
    • ARUP Laboratories
    • Roche Molecular Systems Inc.
    • Dako Inc.
    • Qiagen Ltd.
    • bioMerieux Inc.
    • Ventana Medical Systems Inc.
    • Abbott Molecular Inc.
    • Myriad Genetics Inc.
    • Biogenex Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Leica Biosystems Nussloch GmbH
    • Others

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Companion Diagnostics Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Companion Diagnostics Market, by Product Type 2019-2032 (USD Million)
  • TABLE Companion Diagnostics Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Companion Diagnostics Market, by Application 2019-2032 (USD Million)
  • TABLE Companion Diagnostics Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Companion Diagnostics Market, by Technology 2019-2032 (USD Million)
  • TABLE Companion Diagnostics Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Companion Diagnostics Market, by End User 2019-2032 (USD Million)
  • TABLE Companion Diagnostics Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Companion Diagnostics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Companion Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Companion Diagnostics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Companion Diagnostics Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Companion Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE North America Companion Diagnostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Companion Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Companion Diagnostics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Companion Diagnostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Companion Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Companion Diagnostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Companion Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Companion Diagnostics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Companion Diagnostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Companion Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Companion Diagnostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Companion Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Companion Diagnostics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Companion Diagnostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Companion Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Companion Diagnostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Companion Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Companion Diagnostics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Companion Diagnostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Companion Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Companion Diagnostics Market, by End User, 2019-2032 (USD Million)
目次
Product Code: ANV2573

REPORT HIGHLIGHT

Companion Diagnostics Market size was valued at USD 6,978.12 Million in 2023, expanding at a CAGR of 12.2% from 2024 to 2032.

A companion diagnostic is a medical instrument, frequently an in vitro diagnostic (IVD), that offers data necessary for the safe and efficient administration of a related medication or biological product. It identifies patients who are likely to be at increased risk for serious side effects due to the treatment with a particular therapeutic product. In addition, there is an increasing prevalence of carcinogenic diseases which increases the need for effective genomic testing, leading to global demand for companion diagnostics. However, high capital investment is necessary for the discovery, development and validation of biomarkers, which is hindering the growth of the market. Furthermore, companion diagnostics are increasingly used in drug development by healthcare providers which caused substantial growth in the market.

Companion Diagnostics Market- Market Dynamics

Growing Significance of Personalized Medicines

There is a growing awareness of personalized medicines as they allow for treatments that are tailored to the specific genetic makeup or characteristics of an individual patient. Companion diagnostics help identify biomarkers or genetic variations that can predict how a patient will respond to a particular treatment. This enables physicians to prescribe the most suitable medication for each patient based on their unique genetic profile. These tests empower healthcare providers to make informed clinical decisions and avoid the risk of unnecessary events. Therefore the growing significance of personalized medicines and companion diagnostics represents a paradigm shift in healthcare towards more precise, effective, and patient-centered approaches to treatment.

Companion Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.2% over the forecast period (2024-2032)

Based on product type segmentation, the assay, kits & reagents segments dominated the market

Based on end user segmentation, the pharma and biotech segment dominates the market and is likely to maintain its dominance during the forecast period

Based on region, North America was the leading revenue generator in 2023

Companion Diagnostics Market- Segmentation Analysis:

The Global Companion Diagnostics Market is segmented based on Product Type, Technology, Application, End User, and Region.

The market is divided into two categories based on product type: assay, kits & reagents and software & services. The assay, kits & reagents segments dominated the market due to the availability of a wide variety of products and the growing usage of assays and in the healthcare sector.

The market is divided into three categories based on end users: pharma & biotech companies, clinical research organizations and reference laboratories. The pharma and biotech segment dominates the market and is likely to maintain its dominance during the forecast period. The rising adoption of companion diagnostics is due to the increasing significance of drug development in the healthcare industry.

Companion Diagnostics Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

The market for companion diagnostics is dominated by North America. The presence of numerous prominent companion diagnostics vendors and open clinical research facilities, the easy accessibility of technologically advanced devices and tools, and the significantly changed medical services infrastructure in the US and Canada are all factors contributing to the growth of the friend diagnostics market in North America. Furthermore, Asia-Pacific offers lucrative opportunities for market participants because of the region's high population base, growing awareness of companion diagnostics, improved medical care infrastructure, and growing demand for cutting-edge therapies. For instance, in November 2023, the FDA approved the FoundationOne CDx for use as a companion diagnostic to identify patients with advanced hormone receptor-positive, advanced breast cancer who are eligible for treatment.

Companion Diagnostics Market- Competitive Landscape:

Companies with a strong international presence and distribution network have an advantage in reaching healthcare providers and patients globally. The key market players in companion diagnostics include Abbott Molecular Inc., Thermo Fisher Scientific Inc., Dako Inc., Qiagen Ltd, etc. have distinct technological capabilities and expertise in companion diagnostics development. For instance, Thermo Fisher Scientific is known for its expertise in molecular diagnostics and has a wide range of offerings in this area. while Abbott Molecular Inc. has a strong portfolio of molecular assays. Compliance with regulatory requirements, such as FDA approvals and CE marking in Europe, is crucial in the companion diagnostics market. Companies with a track record of successful regulatory approvals and adherence to quality standards may have a stronger position.

Recent Developments:

In November 2023, Foundation Medicine Inc. an American molecular insight company announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOneCDx to be used as a companion diagnostic for AstraZeneca's Truqap.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPANION DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

ARUP Laboratories

Roche Molecular Systems Inc.

Dako Inc.

Qiagen Ltd.

bioMerieux Inc.

Ventana Medical Systems Inc.

Abbott Molecular Inc.

Myriad Genetics Inc.

Biogenex Laboratories, Inc.

Thermo Fisher Scientific Inc.

Leica Biosystems Nussloch GmbH

Others

GLOBAL COMPANION DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Assay, Kits & Reagents
  • Software & Services

GLOBAL COMPANION DIAGNOSTICS MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Neurological Diseases

GLOBAL COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Immunohistochemistry
  • Molecular Diagnostics
  • In-situ Hybridization
  • FISH
  • CISH

GLOBAL COMPANION DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharma and Biotech Companies
  • Clinical Research Organizations
  • Reference Laboratories

GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Companion Diagnostics Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Companion Diagnostics Market Snippet by Product Type
    • 2.1.2.Companion Diagnostics Market Snippet by Application
    • 2.1.3.Companion Diagnostics Market Snippet by Technology
    • 2.1.4.Companion Diagnostics Market Snippet by End User
    • 2.1.5.Companion Diagnostics Market Snippet by Country
    • 2.1.6.Companion Diagnostics Market Snippet by Region
  • 2.2.Competitive Insights

3.Companion Diagnostics Key Market Trends

  • 3.1.Companion Diagnostics Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Companion Diagnostics Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Companion Diagnostics Market Opportunities
  • 3.4.Companion Diagnostics Market Future Trends

4.Companion Diagnostics Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Companion Diagnostics Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Companion Diagnostics Market Landscape

  • 6.1.Companion Diagnostics Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Companion Diagnostics Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Assay, Kits & Reagents
    • 7.1.3.Software & Services

8.Companion Diagnostics Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Oncology
    • 8.1.3.Cardiovascular Diseases
    • 8.1.4.Infectious Diseases
    • 8.1.5.Neurological Diseases

9.Companion Diagnostics Market - By Technology

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 9.1.2.Immunohistochemistry
    • 9.1.3.Molecular Diagnostics
    • 9.1.4.In-situ Hybridization
    • 9.1.5.FISH
    • 9.1.6.CISH

10.Companion Diagnostics Market - By End User

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2.Pharma and Biotech Companies
    • 10.1.3.Clinical Research Organizations
    • 10.1.4.Reference Laboratories

11.Companion Diagnostics Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Companion Diagnostics Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Companion Diagnostics Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Companion Diagnostics Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Companion Diagnostics Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Companion Diagnostics Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Companion Diagnostics Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.ARUP Laboratories
    • 12.2.2.Roche Molecular Systems Inc.
    • 12.2.3.Dako Inc.
    • 12.2.4.Qiagen Ltd.
    • 12.2.5.bioMerieux Inc.
    • 12.2.6.Ventana Medical Systems Inc.
    • 12.2.7.Abbott Molecular Inc.
    • 12.2.8.Myriad Genetics Inc.
    • 12.2.9.Biogenex Laboratories, Inc.
    • 12.2.10.Thermo Fisher Scientific Inc.
    • 12.2.11.Leica Biosystems Nussloch GmbH
    • 12.2.12.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us